StockWatch
·
Pharmaceuticals
Quarterly Result30 Oct 2026, 06:33 pm

Lyka Labs Approves Q2 Unaudited Results, Reappointment of Director

AI Summary

Lyka Labs Ltd announced its unaudited financial results for the second quarter ended September 30, 2026. The Board of Directors also approved the draft notice for a postal ballot to seek shareholder consent for the re-appointment of Mr. Neeraj Golas as an Independent Director for a period of three consecutive years commencing January 16, 2027. The company reported total income of ₹4,478.91 Lacs for the quarter, with a net profit after tax of ₹131.50 Lacs. The financial results were reviewed by D. Kothary & Co., Chartered Accountants, who provided an unqualified conclusion. The company also noted that figures have been restated due to the sanctioned Scheme of Amalgamation for the merger of Lyka Export Limited with Lyka Labs Limited.

Key Highlights

  • Approved unaudited financial results for Q2 ended September 30, 2026.
  • To seek shareholder approval for re-appointment of Independent Director.
  • Total income reported at ₹4,478.91 Lacs for the quarter.
  • Net profit after tax stood at ₹131.50 Lacs.
  • Financials restated due to approved amalgamation scheme.